Trial intelligence / Profile preview

Intrathecal midazolam for spinal block characteristics and postoperative pain control

IRCT2016063028712N1Phase 4Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of midazolam in postoperative pain, sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Block characteristics and Postoperative pain control. Started Dec 2016; status: completed.

02

Drugs

midazolam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT2016063028712N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016063028712N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call